These are mechanically computed values based on a residual income model. They are not a forecast of market prices or a recommendation of any investment action, and do not predict or guarantee future share prices. Per-share values are adjusted to the latest share basis for stock splits. Historical values are computed retrospectively using current guidance-achievement statistics.
| Metric | Current Period | Same Period of Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥40.40B | ¥35.57B | +13.6% |
| Operating Income | ¥3.45B | ¥2.34B | +47.5% |
| Ordinary Income | ¥4.31B | ¥1.61B | +168.5% |
| Net Income | ¥3.26B | ¥1.04B | +212.2% |
| ROE | 3.1% | 1.0% | - |
The first quarter of the fiscal year ending March 2027 saw increases in both revenue and profit, with multi-stage margin improvement progressing against a backdrop of price revisions and stable costs. Revenue was ¥40.40B (+13.6% YoY), Operating Income was ¥3.45B (+47.5%), Ordinary Income was ¥4.31B (+168.5%), and Net Income was ¥3.26B (+212.2%). While positive operating leverage emerged as the increase in SG&A expenses (+11.8%) remained below revenue growth (+13.6%), temporary factors also made a significant contribution to the substantial increases in Ordinary Income and Net Income, including ¥0.37B in foreign exchange gains and ¥0.55B in extraordinary income, including gains on the sale of investment securities.
【Revenue】Revenue was ¥40.40B, an increase of +13.6% YoY. The core Superabsorbent Polymers segment led growth with revenue of ¥31.87B (78.9% of total revenue, +14.1% YoY), while the Functional Materials segment also contributed to the increase with revenue of ¥8.48B (21.0% of total revenue, +11.9% YoY). Both segments recorded revenue growth, indicating improvement driven by both price revisions and volume.
【Profit and Loss】Operating Income was ¥3.45B (+47.5% YoY). Gross margin improved to 22.7% (+1.7pt YoY), while the Operating Income margin improved to 8.5% (+2.0pt) despite an SG&A expense ratio of 14.2%. In non-operating items, non-operating income of ¥0.95B, including ¥0.37B in foreign exchange gains, contributed to an increase in Ordinary Income to ¥4.31B (+168.5%). In addition, extraordinary income of ¥0.55B, primarily gains on the sale of investment securities, lifted Profit Before Tax to ¥4.81B. After deducting income taxes and other taxes of ¥1.55B (effective tax rate: 32.2%), Net Income was ¥3.26B (+212.2% YoY); the difference between Ordinary Income and Net Income was primarily attributable to the tax burden. Both revenue and profit exceeded the previous year, reflecting a combination of improved core profitability and temporary non-operating and extraordinary gains and losses.
The Superabsorbent Polymers segment is the core business, with revenue of ¥31.87B (+14.1% YoY), Operating Income of ¥2.70B (+26.7%), and an Operating Income margin of 8.5%, accounting for 78.9% of revenue and 78.3% of profit. The Functional Materials segment recorded revenue of ¥8.48B (+11.9% YoY) and Operating Income of ¥0.74B, a substantial increase of +297.3% YoY, resulting in a margin of 8.8%, slightly exceeding that of Superabsorbent Polymers. This substantial increase in profit reflected the base effect from an impairment loss of ¥0.19B recognized for manufacturing equipment at the Chiba Plant in the same period of the previous year. Although an impairment loss of ¥0.03B was also recorded at the same plant during the current period, the amount was smaller and profitability improved. The Other segment recorded revenue of ¥0.27B (+2.2% YoY) and Operating Income of ¥0.006B (-66.7% YoY), representing a decline in profit, although its scale is small relative to the total. The structure in which a single segment accounts for the majority of profit indicates high sensitivity to demand and price fluctuations in that business.
【Profitability】The Operating Income margin was 8.5%, improving from 6.6% in the same period of the previous year, while the Net Income margin improved substantially to 8.1% from 2.9%. R&D expenses as a percentage of revenue were 2.2% (¥0.89B). 【Cash Quality】Inventories rose significantly to ¥28.98B, an increase of +40.0% YoY, growing faster than revenue (+13.6%). Cash and deposits were ¥15.16B, down from ¥18.22B in the same period of the previous year, suggesting that increased working capital may have raised funding requirements. 【Investment Efficiency】ROE was 3.1% (calculated simply based on quarterly profit and net assets at the end of the period), while ROA was 2.0% (Net Income/total assets). Total asset turnover remained low, with higher inventories weighing on asset efficiency. 【Financial Soundness】The Equity Ratio was 65.8%, slightly down from 67.8% in the same period of the previous year. Liquidity remained ample, with a current ratio of 232.4% and a quick ratio of 155.4%; however, short-term borrowings surged to ¥9.74B, an increase of +227.1% YoY. The ratio of interest-bearing debt (total short- and long-term borrowings of ¥24.24B) to net assets was 23.0%. The total liabilities-to-net-assets ratio (equivalent to D/E) was 0.52x, while interest coverage, measured as EBIT divided by interest expense, was approximately 46.6x, indicating robust debt-servicing capacity.
As cash flow statement data has not been disclosed, funding trends are analyzed based on changes in the balance sheet. Cash and deposits declined to ¥15.16B from ¥18.22B in the same period of the previous year, while inventories increased from ¥20.70B to ¥28.98B, or +40.0%, during the period, suggesting that inventory buildup was the primary use of funds. In response to this increased working capital requirement, short-term borrowings surged from ¥2.98B to ¥9.74B, or +227.1%, indicating that part of the inventory buildup was financed through short-term funding. Meanwhile, treasury stock declined substantially from a negative balance of ¥4.20B to ¥0.35B, suggesting the possibility of cash generation through disposal or other transactions. The simultaneous decline in cash and deposits and increase in short-term liabilities indicates that normalization of inventory turnover will be a key focus in evaluating the Company’s cash-generation capacity from operating activities.
Recurring earnings improvement has been supported by successive increases in gross and Operating Income margins, suggesting that the improvement in core business margins is structural in nature. At the same time, temporary factors made a significant contribution to the increase in Ordinary Income and Net Income: foreign exchange gains accounted for ¥0.37B of non-operating income of ¥0.95B, equivalent to approximately 10.8% of Operating Income. In addition, extraordinary income of ¥0.55B was primarily composed of gains on the sale of investment securities, reaching approximately 16.8% of Net Income of ¥3.26B and therefore representing a non-negligible temporary factor. Extraordinary losses remained limited at a total of ¥0.05B, comprising an impairment loss of ¥0.03B and a loss on disposal of fixed assets of ¥0.02B. The structure in which Net Income was ¥3.26B after deducting income taxes and other taxes of ¥1.55B (effective tax rate: 32.2%) from Profit Before Tax of ¥4.81B indicates that the difference between Ordinary Income and Net Income was primarily attributable to the tax burden. Accordingly, while the improvement in core profitability appears to have a strong sustainable aspect, determining the level of core earnings excluding temporary foreign exchange gains and gains on the sale of investment securities will be important in assessing future earnings quality.
The Full-Year progress rates were 24.5% for revenue (¥40.40B against ¥165.00B), 31.4% for Operating Income (¥3.45B against ¥11.00B), 38.5% for Ordinary Income (¥4.31B against ¥11.20B), and 40.8% for Net Income (¥3.26B against the assumed ¥8.00B), indicating progress ahead of the simple quarterly allocation benchmark of 25%. The particularly high progress rates for Ordinary Income and Net Income appear to reflect contributions from the aforementioned temporary factors, namely foreign exchange gains and gains on the sale of investment securities. The Company’s Full-Year forecast calls for revenue growth of +11.2% YoY, while projecting declines of -24.0% in Operating Income and -26.6% in Ordinary Income, contrasting with the substantial profit increases recorded in Q1. This Company plan is consistent with a conservative incorporation of potential headwinds in the second half, such as raw material prices and inventory adjustment costs, and suggests that the Full-Year profit level may normalize relative to Q1.
The Full-Year dividend forecast is ¥70.00 per share, representing a Payout Ratio of 56.2% against forecast Full-Year EPS of ¥124.46. During the current quarter, the Company revised its dividend forecast and announced a change in its dividend policy involving the introduction of a DOE (dividend on equity) approach. A 5-for-1 stock split of common shares was implemented on April 1, 2026, and it should be noted that the current-period dividend amounts are stated on an actual pre-split basis (on a post-split equivalent basis, they are said to correspond to ¥20 for the interim dividend, ¥24 for the year-end dividend, and ¥44 for the full year). The dividend for the same period of the previous year was ¥100 on a pre-split basis, so the impact of the stock split must be considered in making a simple comparison. A Payout Ratio of 56.2% appears to be within an acceptable range in light of cash and deposits of ¥15.16B and the Company’s low-leverage financial structure.
Segment concentration risk: The Superabsorbent Polymers segment accounts for 78.9% of revenue and 78.3% of Operating Income, resulting in high sensitivity of overall earnings to price and demand fluctuations in this business. Trends in acrylic acid prices, the raw material, and demand for disposable diapers and hygiene materials may affect earnings.
Working capital risk: Inventories increased +40.0% YoY, substantially faster than revenue growth (+13.6%), and stagnant inventory could weigh on cash-generation capacity. Short-term borrowings also surged by +227.1% YoY in response, making normalization of working capital an issue going forward.
Foreign exchange sensitivity: Foreign exchange gains of ¥0.37B included in non-operating income were equivalent to approximately 10.8% of Operating Income, indicating a moderate impact of foreign exchange movements on earnings. These gains are temporary in nature and are expected to normalize over the Full Year.
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income margin | 8.5% | 8.7% (4.2%–14.2%) | -0.2pt |
| Net Income margin | 8.1% | 7.0% (3.2%–10.6%) | +1.0pt |
The Operating Income margin is in line with the industry median, while the Net Income margin exceeds the median, with non-operating and extraordinary gains and losses, including temporary factors, lifting the Net Income level.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue growth rate (YoY) | 13.6% | 6.2% (-1.1%–14.6%) | +7.4pt |
Revenue growth is substantially above the industry median and is close to the upper bound of the IQR.
※Source: Compiled by the Company
Gross margin and Operating Income margin improved in successive stages against a backdrop of price revisions and stable costs, with positive operating leverage emerging as the increase in SG&A expenses (+11.8%) remained below revenue growth (+13.6%). The Functional Materials segment recorded a substantial +297.3% increase in Operating Income, partly due to the base effect from the impairment loss recognized in the previous year, contributing to an overall strengthening of the earnings profile.
Although the Full-Year progress rate for Net Income is high at 40.8%, the contribution of temporary factors—including foreign exchange gains equivalent to approximately 10.8% of Operating Income and extraordinary income primarily comprising gains on the sale of investment securities equivalent to approximately 16.8% of Net Income—should be considered when evaluating the Full-Year profit level.
Inventories and short-term borrowings increased simultaneously by +40.0% and +227.1%, respectively. Although liquidity remains ample, working capital efficiency has declined from the same period of the previous year. Normalization of inventory turnover will be a key monitoring point in evaluating future cash-generation capacity.
This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson-type model with an explicit five-year fade). It is not a forecast of the market share price or a recommendation to take any specific investment action.
| Scenario | Theoretical Share Price |
|---|---|
| bear | ¥1,533 |
| base | ¥1,573 |
| bull | ¥1,590 |
| Calculation Assumption | Value |
|---|---|
| Book value per share (BPS) | ¥1,636 |
| Adjusted forecast EPS | ¥136.9 |
| Cost of equity capital r | 9.77% (10-year Japanese Government Bond 2.77% + equity risk premium 6.00% + size premium 1.00%) |
| Persistence coefficient of residual income ω / explicit forecast period | 0.62 / 5 years |
| Assumed Payout Ratio | 56.2% |
| Forecast EPS confidence adjustment | ×1.100 (based on progress ahead of the Full-Year forecast) |
| implied PBR / PER |
Sensitivity: ¥1,531–¥1,618 at ±1% for the cost of equity capital, and ¥1,571–¥1,575 at ±0.1 for ω.
Notes:
(Calculation model: residual income model / interest-rate reference month: 2026-07 / this value does not forecast or guarantee the future share price)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting a professional as necessary.
---End of Report---
| 0.96x / 11.5x |